Adopting a single meal a day (OMAD) regimen, even with identical caloric intake, allows for increased fat burning and lowered blood glucose without a loss of muscle mass or physical performance.

noli's read

Intermittent fasting and the OMAD model are subjects of intensive study. Research confirms that a restricted eating window can improve insulin sensitivity and lipid metabolism, as suggested by a study published in 'Cell Metabolism' (RCT) on animal models and certain human clinical trials. However, the assertion that there is 'no reduction' in muscle mass is nuanced: while possible if protein intake is maintained, the risk of muscle loss exists in elderly individuals or those not engaging in sufficient physical resistance training (systematic review, 'JBI Evidence Synthesis'). The idea that metabolism remains identical solely due to timing is still debated; the observed fat loss is often correlated with a spontaneous caloric deficit rather than timing alone. Finally, data on long-term athletic performance (aerobic/strength) remain heterogeneous and depend heavily on the individual's profile. This is a promising approach for metabolic management, but the results are not universal.

the sources

1. 1Cioffi I, Evangelista A, Ponzo V, et al. 2018
2. 2Lowe DA, Wu N, Rohdin-Bibby L, et al. 2020
3. 3Liu D, Huang Y, Huang C, et al. 2022
4. 4Jamshed H, Steger FL, Bryan DR, et al. 2022